Table I.
Group | Rats (n) | Treatment | Experimental methods |
---|---|---|---|
I | 7 | Sham-operated | RT-qPCR/WB/IHC/BBB/MWT/TWL |
II | 7 | Model (operation only) | RT-qPCR/WB/IHC/BBB/MWT/TWL |
III | 7 | EA Model (operation + EA) | RT-qPCR/WB/IHC/BBB/MWT/TWL |
IV | 7 | EA Model + HSV-IGF-1 | RT-qPCR/WB/IHC/BBB/MWT/TWL |
V | 7 | EA Model + HSV-pNX-CMV | RT-qPCR/WB/IHC/BBB/MWT/TWL |
VI | 7 | EA Model + HSV-siRNA-IGF-1 | RT-qPCR/WB/IHC/BBB/MWT/TWL |
VII | 7 | EA Model + HSV-pNX-U6 | RT-qPCR/WB/IHC/BBB/MWT/TWL |
Model, dorsal root ganglionectomy injury; EA, electro-acupuncture; IGF-1, insulin-like growth factor 1; siRNA, small interfering RNA; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; WB, western blotting; IHC, immunohistochemistry; BBB, Basso, Beattie, Bresnahan score; MWT, mechanical withdrawal threshold; TWL, thermal withdrawal latency.